Doctor Doctor… Give Me the News

In the late 1960s, Alvan Feinstein — professor at the Yale University School of Medicine — published Clinical Judgment. The medical world was never the same again.

Up to that point, the practice of medicine was heavily based on the amorphous concept of ‘clinical reasoning’ — a highly biased and surprisingly unempirical process that lead to physicians exercising decision making without checks or adequate control. Feinstein’s publication brought intense scrutiny levelled at medical decision making, increasing the awareness of weaknesses in what was considered ‘standard best practice’ across the full spectrum of the healthcare industry.

In brief, Feinstein’s approach attempted to anchor policies and procedures not to the current practices or beliefs held by experts, but to (investment in) medical experimentation and the application of those results in practice. Here, ‘evidence-based medicine’ ushered in a new gold-standard that held the capacity to adapt along with the times. Additionally, this capacity to evolve doubly benefited the practice of healthcare alongside keeping pace with advancements in technology to always putting the patient’s needs (not the practitioner’s values or procedural expertise) first and foremost.

How evidence-based medicine affected the health economy

Alongside this paradigm shift occurring in the medical workforce, access to healthcare across the globe skyrocketed. Patient treatment numbers increased, the penetration of first-world health practices into third-world countries was suddenly greater and more accessible than ever before, and as a result we in general became healthier, living longer. As health garnered more and more patient-investment and evidence-based medical teachings entered medical education, a new medical workforce of highly educated younger practitioners began to enter the fray — all extolling the virtues for rigorous R+D, continuous experimentation and strict statistical analysis in practice.

Inevitably, as we began treating health better, our healthcare institutions fell under increasing levels of strain. Last month I reported on the soon-to-be dire situation that these same institutions would undergo in the not too distant future. With the rate of life expectancy and access to health disproportionately outstripping the healthcare facilities that can service them — in design, in capacity, in rapidity — the global A+D community is currently finding itself called upon to answer to an enormous array of stakeholder needs.

But what does this have to do with the design community?

At its very core, evidence-based medicine sought to achieve something deceptively simple: understanding the patient’s recovery possibilities more and the practitioner’s abilities less.

In our post-digital age, a diversity of needs and demands continues to grow for evidence-based approaches to designing our material environments. Whether residential, commercial, institutional or cultural, our creative practitioners are increasingly performing intelligence-gathering activities as the core of a new breed of design thinking. Through employing design processes intended to support existing user behaviours, limitations and needs, we’ve rethought the end-user: someone who is not forced to adapt themselves to the object of design, but adapting the object of design to the parameters and limits of their body. Across the entire playing field of A+D, such approaches have engendered a more cost-effective and well-liked end product (not to mention a loyal consumer).

And, this is relatively — in fact, surprisingly — a recent phenomenon. In 2008, a landmark systematic review for the design and health industries conclusively proved that designers are as importantly positioned as doctors for creating material healthcare worlds that actively contribute to patient recovery.

Simply, it’s design that embraces everyone … always.

Follow Zenith’s evidence-based design journey here.